Amsterdam UMC - Cancer Center Amsterdam

What Amsterdam UMC - Cancer Center Amsterdam does

Amsterdam UMC is a Dutch university medical center formed through the integration of two academic hospitals — Academisch Medisch Centrum (AMC), affiliated with the University of Amsterdam (UvA), and Vrije Universiteit medisch centrum (VUmc), affiliated with Vrije Universiteit Amsterdam (VU). It operates from two main locations in Amsterdam (Meibergdreef 9 and De Boelelaan 1117) and serves as an integrated platform for tertiary patient care, biomedical research, and medical education. The organization employs 15,000-17,000 staff, treats 35,000+ patients annually, and encompasses eight research institutes including Cancer Center Amsterdam, Amsterdam Neuroscience, Amsterdam Cardiovascular Sciences, Amsterdam Gastroenterology Endocrinology Metabolism, and Amsterdam Public Health. Cancer Center Amsterdam is a dedicated cancer research and treatment institute within this ecosystem.

The organization monetizes through three core revenue streams: (1) patient care reimbursement via the Dutch mandatory health insurance system based on diagnosis-related groups (DBC tariffs), (2) research grants from government bodies including NWO, European Horizon/ERC programs, and healthcare foundations, and (3) education and training programs funded through UvA and VU partnerships, including PhD programs and specialist training. Customer segments span patients requiring complex or specialized care, medical researchers, medical trainees, and women's health and complex-critical patient subgroups. Marketing channels emphasize scientific credibility through the corporate website, press relations, public events (e.g., the annual Anatomy Lesson at the Concertgebouw), and the careers platform, while patient acquisition runs through the Dutch GP/specialist referral system.

Core technology infrastructure includes 14 dedicated research facilities spanning a CRISPR Center, Genomics, Biobank, Metabolomics, Microscopy and Cytometry, Induced Pluripotent Stem Cells, Functional Genomic Screening, Research Imaging, and OncoProteomics, plus advanced clinical assets such as a 7 Tesla MRI scanner, AI-supported ultrasound, and contrast-enhanced ultrasound. Digital health products include the HartWacht (HeartGuard) remote cardiac monitoring app and the IkHerstel post-surgical recovery app. The organization's competitive position rests on statutory designation as a university medical center, integrated talent pipelines through UvA and VU, scale advantages in patient volume and biological sample storage, and active consortia across Europe including the INTERCEPT, FEMCURE, and Palacros partnerships. Notable recent milestones include the first completed Phase 3 in vivo CRISPR gene editing trial (June 2026) and a €37.5M European grant for the INTERCEPT Crohn's disease consortium (January 2025).

Name

Amsterdam UMC - Cancer Center Amsterdam

Legal name

Amsterdam UMC

Website

https://amsterdamumc.org

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Amsterdam UMC is a Dutch non-profit university medical center operating across two Amsterdam hospital sites (15,000-17,000 staff, 35,000+ patients annually). Cancer Center Amsterdam is one of eight research institutes within it, focused on cancer research, clinical trials, and treatment innovation integrated with patient care and academic training.

Ownership category

akta.pro rank

Product category

Academic Medical Center Cancer Research

NAICS

Medical Laboratories (621511), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Research & Trial Central Laboratories (HLAFAMAL), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

• Academic medical center
• Cancer research institute
• Clinical research services
• Medical education programs
• Digital health applications

Headquarters

HQ city

Amsterdam, North Holland

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Patient Care Reimbursement: Healthcare services are reimbursed through the Dutch health insurance system. Dutch citizens are required to have basic health insurance, and hospitals receive compensation based on diagnosis-related groups (DBC) for medical treatments and procedures.
2. Research Grants and Funding: Significant funding from government bodies including NWO (Netherlands Organisation for Scientific Research), European grants (Horizon Europe, ERC), and healthcare research foundations for conducting scientific research and clinical trials.
3. Education and Training: Medical education services including PhD programs, specialist training for medical professionals, and continuous professional development courses funded through educational partnerships with UvA and VU universities.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Amsterdam UMC - Cancer Center Amsterdam is a cancer-focused research institute within Amsterdam UMC, one of the largest academic medical centers in the Netherlands. The institute conducts translational cancer research, develops innovative therapies (including immuno-oncology and CRISPR-based treatments), and integrates research findings into clinical practice through multidisciplinary teams. It supports clinical trials, biomarker discovery, precision oncology, and operates alongside 14+ core research facilities serving the broader Amsterdam UMC ecosystem.

Product overview

Amsterdam UMC is a university medical center operating across two locations (AMC and VUmc) with eight research institutes including Cancer Center Amsterdam, Amsterdam Neuroscience, Amsterdam Cardiovascular Sciences, and Amsterdam Gastroenterology Endocrinology Metabolism. The organization offers a comprehensive platform of 14 core research facilities (Biobank, CRISPR Center, Genomics, Metabolomics, Microscopy, Research Imaging, and others) supporting biomedical research. Digital health products include HartWacht remote monitoring app and IkHerstel recovery app. Educational offerings include the Doctoral School for PhD candidates. The ecosystem combines clinical care, fundamental research, and technology translation through dedicated institutes, shared core facilities, and innovation programs.

Differentiator

Problem solved

Functional benefit

Brands

• Cancer Center Amsterdam: Research institute focused on cancer research and treatment innovation
• Emma Kinderziekenhuis
• Amsterdam Skills Center

Products and services

• Cancer Center Amsterdam Research institute focused on cancer research and treatment innovation, developing groundbreaking treatments and therapies for cancer patients through multidisciplinary research programs.
• CRISPR Center Core facility providing CRISPR gene editing technology and expertise for genetic research and therapy development across Amsterdam UMC research programs.
• Amsterdam UMC Biobank Repository for storing body materials (blood, urine, tissue) with patient consent for medical research purposes.
• Genomics Core Facility Genomics laboratory providing DNA/RNA sequencing and analysis services for research projects.
• Research Imaging Core Center Advanced medical imaging facility providing MRI, microscopy, and cytometry services for research.
• OncoProteomics Facility Proteomics facility specializing in protein analysis for cancer research and diagnostics.
• Functional Genomic Screening Facility High-throughput genomic screening platform for identifying gene functions and genetic interactions.
• Induced Pluripotent Stem Cells Facility iPSC laboratory providing stem cell research services for disease modeling and regenerative medicine.
• Metabolomics Facility Metabolomics laboratory analyzing metabolic profiles for disease research and biomarker discovery.
• Microscopy and Cytometry Facility Advanced microscopy and cell analysis facility for cellular and molecular research.
• HartWacht (HeartGuard) App Digital health application enabling remote monitoring of heart patients at home through blood pressure and arrhythmia measurements using a small measurement device and mobile app.
• IkHerstel Recovery App Mobile application helping patients recover up to 14 days faster after surgery through guided recovery protocols.
• Amsterdam Skills Center Surgical training center where surgeons and operators practice surgical skills 24/7 without patients, featuring simulation and skills training.
• Doctoral School PhD support program providing information, administration, advice, and education for PhD candidates and their supervisors at Amsterdam UMC.
• Mijn Dossier Patient Portal Digital environment allowing patients to view their medical records and health data from Amsterdam UMC locations.
• Amsterdam Neuroscience Research institute focused on understanding the human brain and nervous system, translating insights into effective therapies for neurological and psychiatric disorders.
• Amsterdam Cardiovascular Sciences Research institute working toward preventing and curing cardiovascular diseases through innovative research and clinical applications.
• Emma Kinderziekenhuis (Emma Children's Hospital) Children's hospital within Amsterdam UMC providing specialized pediatric care and research, including rare neurological disease research.
• Amsterdam Gastroenterology Endocrinology Metabolism Research institute covering gastroenterology, endocrinology, and metabolism research including Crohn's disease and obesity studies.
• Amsterdam Institute for Immunology and Infectious Diseases Research institute covering immunology and infectious diseases, including tuberculosis and immune therapy research.
• Amsterdam Movement Sciences Research institute focused on movement sciences research including rehabilitation and post-COVID muscle disorder research.
• Amsterdam Public Health Public health research institute addressing population health, social-economic health determinants, and global health challenges.
• Amsterdam Reproduction & Development Research institute focused on reproduction and development research including women's health and gynecological conditions.

Quantifiable outcome

• 87% relative reduction in hereditary angioedema attacks with CRISPR therapy
• +4 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature11 records

Partnerships

15 partnerships are on record, tiered core and minor.

• European Partners (Palacros)coreStrategic or Co-development Partner · 1 July 2026European collaboration to improve treatment options for pancreatic cancer patients through shared research and clinical expertise.
• Radboud UMCcoreStrategic or Co-development Partner · 1 March 2026FEMCURE project collaboration for women's health research. Partners are developing self-tests, AI-supported ultrasound diagnostics, and targeted therapies for menstrual disorders. The project aims to drastically shorten the 8-11 year diagnostic delay for conditions like endometriosis and fibroids.
• TU EindhovencoreStrategic or Co-development Partner · 1 March 2026FEMCURE project collaboration bringing engineering expertise for diagnostic technology development including advanced imaging techniques and mobile health applications.
• TNOcoreStrategic or Co-development Partner · 1 March 2026FEMCURE project partner contributing research expertise for women's health conditions and diagnostic innovation.
• Voices for WomenminorStrategic or Co-development Partner · 1 March 2026Patient advocacy organization involved in FEMCURE project ensuring patient perspectives are incorporated in research and treatment development.
• Women Inc.minorStrategic or Co-development Partner · 1 March 2026Women's advocacy organization contributing to FEMCURE project for women's healthcare improvement.
• CardioNoVo+coreStrategic or Co-development Partner · 1 February 2026Regional collaboration for heart care aimed at providing treatment at the right place, promoting innovation, and reducing waiting times in cardiovascular care.
• Gender CliniccoreStrategic or Co-development Partner · 1 January 2026Partnership to reduce waiting times for transgender healthcare by combining expertise and resources between Amsterdam UMC and Gender Clinic.
• Amsterdam Pact for Healthier FoodminorStrategic or Co-development Partner · 1 April 2025Amsterdam UMC signed covenant 'Samen eten we Amsterdam gezond, duurzaam en eerlijk' (Together we eat Amsterdam healthy, sustainable and fair) with 11 other major Amsterdam organizations for healthier, sustainable food initiatives.
• European Consortium INTERCEPTcoreStrategic or Co-development Partner · 1 January 2025International consortium led by Amsterdam UMC investigating early detection and treatment of Crohn's disease. Funded by a 37.5 million euro European grant. Includes multiple European research institutions.
• Centre for Sustainable HealthcareminorStrategic or Co-development Partner · 1 August 2024Green Fund partnership supporting sustainability projects within Amsterdam UMC. The Centre helps evaluate and guide practical sustainability initiatives including energy efficiency and waste reduction.
• Amsterdam Skills CentercoreStrategic or Co-development Partner · 1 April 2024Partnership with Amsterdam Skills Center where surgeons and operators from around the world practice surgical skills, enabling faster and more efficient training.
• Dutch Colorectal Cancer GroupcoreStrategic or Co-development Partner · 1 January 2024Collaborative partner in COLLISION trial for liver metastases treatment, comparing thermal ablation to surgical removal in colorectal cancer patients.
• European Consortium (Horizon Grant)coreStrategic or Co-development Partner · 1 November 2023European consortium for obesity research led by Amsterdam UMC epidemiologist Jeroen Lakerveld. Receives over 10 million euros through Horizon grant to identify causes of obesity and develop prevention guidelines.
• Yale UniversitycoreStrategic or Co-development Partner · 1 June 2023Collaborative research with Yale University on brain responses to nutrients in obesity, published in Nature Metabolism. Combined Amsterdam UMC and Yale expertise for the study.

Scale indicators8 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Erasmus MC: Erasmus MC is the other large Dutch university medical center (Rotterdam), comparable to Amsterdam UMC in combining academic research, complex patient care, and medical training across multiple specialty institutes with similar scale and structure.
• Netherlands Cancer Institute (NKI / Antoni van Leeuwenhoek): NKI is a Dutch dedicated cancer research and treatment center, directly comparable to Cancer Center Amsterdam's mission of integrating cancer research with clinical oncology, and competing for similar cancer research grants and clinical trial partnerships.
• Leiden University Medical Center (LUMC): LUMC is another Dutch university medical center with comparable academic research and patient care focus, competing with Amsterdam UMC for NWO grants, top researchers, and complex patient referrals within the Dutch healthcare system.
• University Medical Center Utrecht (UMC Utrecht): UMC Utrecht is a major Dutch academic medical center with overlapping research strengths (cancer, regenerative medicine, imaging) and similar scale, making it a direct competitor for research funding, talent, and patient referrals.
• Radboud University Medical Center (Radboud UMC): Radboud UMC is a Dutch academic medical center comparable to Amsterdam UMC in research scope and a current FEMCURE consortium partner. It competes for similar Dutch and EU research grants and clinical trial activities.

Broad incumbents

• Memorial Sloan Kettering Cancer Center: MSK is a leading global cancer research and treatment institution, comparable to Cancer Center Amsterdam in its integration of oncology research and clinical care, and serves as an international benchmark for translational cancer research output.
• Gustave Roussy: Gustave Roussy is a leading European comprehensive cancer center, comparable to Cancer Center Amsterdam in oncology research depth and clinical trial activity, and competing for European oncology research funding and partnerships.
• MD Anderson Cancer Center: MD Anderson is a global leader in cancer research and treatment, broadly comparable to Cancer Center Amsterdam's mission and a benchmark for translational cancer research, clinical trial scale, and oncology innovation.
• Charité – Universitätsmedizin Berlin: Charité is one of Europe's largest university medical centers, with comparable scale, multi-institute research structure, and broad clinical specialty coverage, competing for European research funding and partnerships.
• Karolinska Institutet / Karolinska University Hospital: Karolinska is a leading European academic medical and research institution in Sweden, comparable to Amsterdam UMC in scale and breadth of biomedical research, and competes for European research grants and international research talent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/amsterdam-umc-cancer-center-amsterdam

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amsterdam UMC - Cancer Center Amsterdam